PACS

VinBrain to Launch AI-centric Solutions to Save Lives and Advance Precision Care at RSNA 2023

Retrieved on: 
Lunedì, Dicembre 4, 2023
Cloud, Liver, Radiology, Microsoft Band, Life expectancy, Stanford University, Cancer, Vingroup, Diagnosis, Microsoft, Hepatocellular carcinoma, Artificial intelligence, SOTA, EDS, Privacy, Exhibition, Knowledge, Fellow, Azure, Health care, Scientific Reports, Medical imaging, Physician, Tuberculosis, HCC, CXR, AI, TACE, HIPAA, Patient, Medicine, NVIDIA, TB, TME, HIS, Learning, Research, R&D, RIS, PACS, EMR, NIST, Health, Graphics processing unit, RSNA, Medical device

Unveiling two impactful AI-centric solutions during the event - DrAid Enterprise Data Solution: Centralization, Transformation, Intelligence; and DrAid Oncology Diagnosis and Treatment, VinBrain takes major steps forward in innovation, aiming to save more lives and advance precision care for everyone.

Key Points: 
  • Unveiling two impactful AI-centric solutions during the event - DrAid Enterprise Data Solution: Centralization, Transformation, Intelligence; and DrAid Oncology Diagnosis and Treatment, VinBrain takes major steps forward in innovation, aiming to save more lives and advance precision care for everyone.
  • Expediting interoperability and streamlining, DrAid Enterprise Data Solution (EDS) is hoped to lead the healthcare transformation towards precision care.
  • Dr. Michael C. Muelly, medical partner of VinBrain shared his point of view about clinical practices and values of the solutions during product launch at RSNA 2023.
  • At RSNA 2023, VinBrain also showcased its commitment to providing accessible healthcare in underserved regions with high tuberculosis burden through DrAid for Tuberculosis Screening (CXR Screening).

NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)

Retrieved on: 
Martedì, Dicembre 12, 2023
Long COVID, Long, CDC, Baylor University, Baylor College of Medicine, COVID-19, Division, Infection, FDA, Pain, ACR, Gait, Cough, Weakness, PACS, Clinical trial, Quell, NSF, MAF, National Science Foundation, Fibromyalgia, American College, Myalgia, Patient, Safety, Memory, BPI, Arthralgia, Pharmaceutical industry

The trial was conducted at the Baylor College of Medicine in collaboration with C2SHIP.

Key Points: 
  • The trial was conducted at the Baylor College of Medicine in collaboration with C2SHIP.
  • The principal investigator was Dr. Bijan Najafi, Professor of Surgery, and clinical director at the Division of Vascular Surgery and Endovascular Therapy, Baylor College of Medicine.
  • According to the Centers for Disease Control and Prevention (CDC), about 10 million Americans have PACS.
  • "This pilot trial suggests that Quell may alleviate fibromyalgia-like pain and other symptoms of Long Covid.

Wake Radiology UNC REX Healthcare Chooses Enlitic’s ENDEX to Augment Their Radiology Business

Retrieved on: 
Mercoledì, Novembre 29, 2023
Radiology, Mammography, Workflow, Eye, PACS, AI, 3D, Artificial intelligence, Intelligence, ROI, Medical imaging

FORT COLLINS, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Enlitic®, Inc. and Wake Radiology UNC REX Healthcare will deploy the ENDEX™ data standardization toolset to help improve their reporting workflows and increase the capacity of their radiologist team.

Key Points: 
  • FORT COLLINS, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Enlitic®, Inc. and Wake Radiology UNC REX Healthcare will deploy the ENDEX™ data standardization toolset to help improve their reporting workflows and increase the capacity of their radiologist team.
  • Wake Radiology reports over 250,000 scans per year and will simplify reading workflows for more than 50 radiologists using ENDEX to standardize their medical imaging studies.
  • By focusing on solving workflow challenges and capacity issues that impact radiology efficiency, Enlitic's AI powered solutions directly influence how radiologists and radiology departments work.
  • "Wake Radiology has always had one eye on the future in order to provide the best service we can.

Research from Philips and Vanderbilt shows how decarbonizing healthcare also helps to reduce cost

Retrieved on: 
Mercoledì, Novembre 29, 2023
Carbon, Google Images, Outline, AEX, Research, Hand, Sustainability, Radiology, Health, Hospital, Vanderbilt University Medical Center, MD, Doctor of Philosophy, Environmental health, PACS, Medical imaging, Climate change, VUMC, LCA, Assistant, Symposium, Patient, Organization, PHG, Global Health, RSNA, Environment

The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally friendly and cost-effective.

Key Points: 
  • The project, which was initially announced in May 2023, shows that sustainable initiatives can be both environmentally friendly and cost-effective.
  • In addition, the energy use of scanners accounted for more than half of the total emissions released from diagnostic radiology.
  • The assessment showed that both technology and healthcare practitioners play a significant role in reducing overall greenhouse gas emissions.
  • With sustainability embedded in everything the company does, Philips is leading the way in innovation to enable healthcare that is connected, inclusive, accessible and sustainable.

Philips launches HealthSuite Imaging, a cloud-based next generation of Vue PACS, with new AI-enabled clinical and operational workflows at #RSNA23

Retrieved on: 
Lunedì, Novembre 27, 2023
Radiology, Digital, Partnership, Health, AWS, AEX, Informatics, PACS, AI, PHG, Information, Amazon Web Services, Medical imaging

Philips HealthSuite Imaging is a next generation cloud-based PACS enabling radiologists and clinicians to adopt new capabilities faster, help improve operational efficiency and enhance patient care.

Key Points: 
  • Philips HealthSuite Imaging is a next generation cloud-based PACS enabling radiologists and clinicians to adopt new capabilities faster, help improve operational efficiency and enhance patient care.
  • Other healthcare systems are now planning their migration to Philips HealthSuite Imaging to take advantage of the new AI-enabled clinical and operational workflows.
  • Through HealthSuite Imaging, Philips continues to extend its clinical innovation focused on enhancing the radiologist experience.
  • Using Amazon Bedrock, Philips is exploring clinical workflow applications across its portfolio in order to automate administrative tasks and enable more accurate diagnoses.

Fujifilm Showcases Enhanced Cloud-based Synapse® Enterprise Imaging Portfolio at the 2023 Radiological Society of North America Conference

Retrieved on: 
Mercoledì, Novembre 22, 2023
Cloud, Radiology, Health, VNA, Mammography, Cardiology, Health care, Pathology, FDA, Case management, Enterprise imaging, PACS, Defense, Synapse, Data mining, AI, 3D, Communication, Fujifilm, McCormick Place, Informatics, Patient, KLAS, Diagnosis, Organization, Heart failure, Algorithm, RSNA, Medical imaging

LEXINGTON, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, will showcase its enhanced Synapse® Enterprise Imaging portfolio in booth #1929 at the upcoming Radiological Society of North America ( RSNA ) conference held November 26 – 30 at McCormick Place in Chicago.

Key Points: 
  • LEXINGTON, Mass., Nov. 22, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, will showcase its enhanced Synapse® Enterprise Imaging portfolio in booth #1929 at the upcoming Radiological Society of North America ( RSNA ) conference held November 26 – 30 at McCormick Place in Chicago.
  • Fujifilm will showcase the following new specialty-specific features and benefits of Synapse 7x version 7.4 in booth #1929.
  • The technology was acquired by Fujifilm in 2023 and is the only FDA-cleared pathology solution for primary diagnosis with multiple scanners.
  • In addition to these new features, Fujifilm’s entire Synapse Enterprise Imaging portfolio will be available for demonstration, including:
    Synapse Cloud provides a scalable and secure environment to host and manage the Synapse Enterprise Imaging portfolio.

Terran Biosciences Receives FDA Clearance for NM-101, the industry’s first software for the analysis of neuromelanin-sensitive MRI

Retrieved on: 
Mercoledì, Dicembre 20, 2023
Software, Research, Radiology, Pharmaceutical, Mental Health, Technology, Hospitals, Health Technology, Science, Neurology, Biotechnology, FDA, Health, Psychiatry, Associate, MRI, Locus coeruleus, DSM-IV codes, Physician, Albert Einstein's brain, Hospital, Brain, Doctor of Philosophy, News, PACS, Substantia nigra, Columbia University, Mental Hygiene, University, Biomedicine, CNS, Molecular medicine, Schizophrenia, Assistant, Patient, Diagnosis, Meta-analysis, Neuroscience, Therapy, Algorithm, Automation, Medical imaging

Terran Biosciences, Inc. ("Terran"), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has received FDA clearance to market NM-101, a cloud-based software platform to analyze neuromelanin-sensitive MRI scans.

Key Points: 
  • Terran Biosciences, Inc. ("Terran"), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has received FDA clearance to market NM-101, a cloud-based software platform to analyze neuromelanin-sensitive MRI scans.
  • Currently, there is no other FDA-cleared software indicated for the analysis of neuromelanin MRI on the market, making Terran’s technology the world’s first.
  • NM-101 is a cloud-based analysis platform that is able to seamlessly integrate into existing workflows at hospitals and imaging centers.
  • NM-101 contains algorithms that enabled for the first time the fully automated analysis and the cross-scanner harmonization of neuromelanin MRI scans [8-10,12,13].

OTORIO Researchers Uncover Critical Vulnerabilities in Building Security Systems

Retrieved on: 
Mercoledì, Dicembre 20, 2023
Black hat, Research, TEL, Open, PACS, IP, Communication, Online shopping

TEL AVIV, Israel , Dec. 19, 2023 /PRNewswire/ -- OTORIO, a leading cybersecurity company, recently revealed groundbreaking research on the security risks associated with modern Physical Access Control Systems (PACS), presented at Black Hat Europe 2023.

Key Points: 
  • Modern PACS designed to enhance building security inadvertently serve as entry points into internal IP networks.
  • TEL AVIV, Israel , Dec. 19, 2023 /PRNewswire/ -- OTORIO , a leading cybersecurity company, recently revealed groundbreaking research on the security risks associated with modern Physical Access Control Systems (PACS), presented at Black Hat Europe 2023.
  • Bypassing the latest physical security access control systems, allowing unauthorized access to secure facilities.
  • This discovery raises concerns about the security of devices utilizing OSDP, highlighting the need for a comprehensive revaluation of building access control measures.

Samba TV Study Shows that 2024 Political Advertisers Face Steep Challenges Reaching the Crucial Youth Vote

Retrieved on: 
Giovedì, Novembre 16, 2023
ID, Perception, GOP, Gen, Samba, SAN, Samba TV, Democrat, PACS, Senate, Social media, Friends, Republican, Generation Z, Health, Family, News, Thought, Television

At a time of all-time low trust and dissatisfaction in media, this political season it will be pertinent for advertisers to look to comprehensive omniscreen targeting and measurement.

Key Points: 
  • At a time of all-time low trust and dissatisfaction in media, this political season it will be pertinent for advertisers to look to comprehensive omniscreen targeting and measurement.
  • Navin continued, “Despite the dwindling trust in traditional media, it remains a vital platform for reaching voters.
  • However, the 2024 election will demand that campaigns incorporate rigorous targeting and measurement strategies to prevent oversaturation.
  • Majority of Americans are excited to vote in 2024, as top issues differ ​by political party
    While up to 67% of Republicans and Democrats are excited to vote in the 2024 presidential election, only 42% of undecided voters are looking forward to it.

Greater Houston Port Bureau Announces Vincent DiCosimo as Board Chairman

Retrieved on: 
Mercoledì, Dicembre 13, 2023
Trucking, Rail, Maritime, Transport, Chemicals, Plastics, Oil, Gas, Manufacturing, Energy, Logistics, Supply Chain Management, Acquisition, Port, Amegy Bank of Texas, Multimedia, PACS, Targa, Targa Resources, Marketing, Suderman, Enterprise Products, EVP, Propane, Maritime and Port Bureau, LP, Greater Houston Partnership, Knowledge, Government, Moran Shipping Agencies, SVP, Management, Shipbuilding

The Greater Houston Port Bureau (“Port Bureau”) Board of Directors is pleased to announce that Vincent DiCosimo, vice president of government affairs at Targa Resources, will assume the position of the chairman of the board on January 1, 2024.

Key Points: 
  • The Greater Houston Port Bureau (“Port Bureau”) Board of Directors is pleased to announce that Vincent DiCosimo, vice president of government affairs at Targa Resources, will assume the position of the chairman of the board on January 1, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20231212153544/en/
    Vincent DiCosimo, vice president of government affairs at Targa Resources, will assume the position of the chairman of the board at the Greater Houston Port Bureau on January 1, 2024.
  • The Greater Houston Port Bureau is a non-profit maritime trade association with over 240 member companies working together to advance the port region.
  • For more information, visit www.txgulf.org (Photo: Business Wire)
    Bernt Netland, the outgoing chairman of the Port Bureau Board said, “Vincent has been a part of the Port Bureau’s board for many years and has been active in his role as vice chair.